Pembrolizumab in combination with platinum-based chemotherapy for treating recurrent, persistent or metastatic cervical cancer

5 October 2022 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...

Read more →

Tackling submission and publication bias

17 July 2017 - Evoniuk and colleagues analysed whether submission and publication bias are based on study outcome. ...

Read more →

NICE terminates four single technology assessments

22 March 2017 -  Appraisals terminated as a result of four sponsors deciding not to submit evidence. ...

Read more →